ISPOR Holds Tuesday Webinar on Health Preferences in HTA
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will hold a webinar on November 2nd at 11:00 AM EDT on health [...]
Value in Health Editors Issue Call for Papers on Drug Costs
The editors of Value in Health have issued a call for papers related to prescription drug costs throughout the product [...]
Collaborative RWE Registry Promises Data Transparency
The Real World Evidence (RWE) Registry was formed by the International Society for Pharmacoeconomics and Outcomes (ISPOR), the International Society for [...]
ISPOR Article on the Growing Wearable Market and New Applications in Healthcare
A recent article featured in Value & Outcomes Spotlight details the growing use of wearables. These tools can be an [...]
ISPOR Director Discusses Global Commitment to Improving HEOR
Director of Global Networks at the International Society for Pharmacoeconomics and Outcomes (ISPOR) Robert Selby discussed ISPOR’s worldwide initiative intended to [...]
ISPOR Issues Call for Nominations for 2022 President-Elect
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is taking nominations for the role of President-Elect. The position will begin on [...]
Register Now for October ISPOR Webinar on Venture Capital Investment in Healthcare
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is hosting a webinar on October 26th at 11:00 AM EDT on venture [...]
ISPOR Seeks Comments for FDA Guidance on RWD
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is seeking comments for a draft guidance document published by the Food and [...]
New Book on Historic and Future Pharma Trends Now Available
A recently published book authored by Mickey C. Smith, PhD details the multi-faceted issues facing pharma and healthcare. Francis B. [...]
ISPOR 2022 Meeting Seeking Abstracts on RWE and HEOR
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is seeking abstracts for its 2022 meeting, held both in-person and virtually next [...]
Upcoming ISPOR Webinar on Value in Healthcare Decision-Making
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will hold a webinar on decision-making in healthcare on October 26th at 11:00 [...]
New GRACE Cost-Effectiveness Tool Considers Patients’ Wishes and Improves Healthcare Decision-Making
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) tool addresses some of the challenges associated with previous health economics and outcomes research (HEOR) [...]
ISPOR Webinar on Embedded Clinical Trials and RWE Now Available On-Demand
A recent webinar, sponsored by Syneos, focuses on the use of embedded clinical trials in generating real world evidence (RWE). [...]
Recent ISPOR Study Highlights the Use of RWE in Decision-Making
In a recent study published in Value in Health, researchers investigated how real world evidence (RWE) impacted decision-making by the [...]
ISPOR Article on Prescription Drug Price Variation in Last Decade
In a recent article published in Value in Health, the authors investigate pharmaceutical drug prices. They note significant variation among payers; [...]
ISPOR Seeks Survey Respondents to Identify Key HEOR Trends
The Professional Society for Health Economics and Outcomes Research (ISPOR) has issued a survey to understand key trends in health [...]
PhRMA President Discusses Patient Centricity in Value Assessments
President of Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Eileen Cannon shared her thoughts on adding a patient-centered component [...]
ISPOR Article Evaluates Bias Assessment Tools in HEOR
An article published in ISPOR’s Value in Health journal discusses bias assessment tools. The authors distinguish between absolute and relative [...]
Register Today for ISPOR Short Course on Decision-Grade RWE
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will hold a short course from 9:00 AM to 1:30 PM EDT on [...]
Upcoming ISPOR Webinar on Successfully Incorporating External Controls Into Oncology RWE Studies
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will host a webinar on August 12th at 2:00 PM EDT on successfully [...]
ISPOR Article Highlights Substantial Yet Forgotten Impact of Healthcare on Patient Caregivers
An article published in the May/June issue of ISPOR’s Value & Outcomes Spotlight highlights the burden of disease on patient [...]
ISPOR’s Value & Outcomes Spotlight Features Visual Representation Detailing How HEOR Impacts Healthcare Policy and Decision-Making
An article in ISPOR’s May/June issue of its Value & Outcomes Spotlight magazine visually details how health economics and outcomes [...]
New ISPOR Article Highlights Need for Clearly Defining Fit-For-Purpose RWD in Oncology Research, Reveals UReQA RWD Selection Framework
Fit-for-purpose real world data (RWD) is an attractive source of decision-making data. Multiple stakeholders, including regulatory affairs professionals and payers, [...]
Assessing the ISPOR HEOR Competencies Framework in the Real World Could Inform Postgraduate Training
The Professional Society for Health Economics and Outcomes Research (ISPOR) has organized 41 competencies across 13 topics into the ISPOR [...]
Register for Upcoming ISPOR Signal Event on Current HEOR Trends and Applying New Big Data Tools
Register today for a virtual ISPOR event that will take place from 11:00 AM to 12:30 PM EDT on September [...]